Alport syndrome is a rare inherited disorder caused by changes in genes responsible for producing type IV collagen, a structural protein found in the kidneys, inner ears, and eyes. The condition primarily affects kidney function but can also cause hearing loss and specific eye abnormalities. There is currently no definitive cure, but early treatment and regular monitoring can help slow kidney disease and manage associated complications. Regular monitoring, hearing and eye care, genetic counseling, and kidney replacement therapies when necessary provide a comprehensive approach to long-term management.
Alport syndrome results from genetic changes most commonly involving the COL4A3, COL4A4, or COL4A5 genes.
The condition can affect:
Kidney involvement often begins with microscopic blood in the urine. Protein may later appear in the urine as kidney function declines.
Symptoms vary depending on the genetic form and severity.
Possible signs include:
Some individuals may have few noticeable symptoms during the early stages.
Diagnosis may involve several types of testing.
Healthcare providers may recommend:
Genetic testing can help identify the specific gene involved and clarify the inheritance pattern.
Protecting kidney function is a major goal of Alport syndrome treatment.
Medications that reduce pressure within the kidney's filtering units may help reduce protein loss and slow progression of kidney disease.
These commonly include:
Treatment may be started early in some patients, depending on genetic findings, age, proteinuria, blood pressure, and kidney function.
High blood pressure can accelerate kidney damage.
Management may include:
Maintaining appropriate blood pressure is an important part of long-term kidney care.
Research continues to evaluate therapies that could slow the progression of Alport-related kidney disease.
Studies have investigated approaches involving:
Some treatments may be available only through specific clinical circumstances or research studies.
If kidney function eventually becomes severely impaired, treatment may involve kidney replacement therapy.
Possible approaches include:
Kidney transplantation is an established treatment for kidney failure caused by Alport syndrome.
Hearing loss is common in some forms of Alport syndrome.
Regular hearing assessments can identify changes early.
Management may include:
Early intervention can help preserve communication and educational or occupational functioning.
Alport syndrome can cause characteristic changes in the lens, retina, or other eye structures.
Regular ophthalmologic examinations may help identify abnormalities.
Most eye findings do not cause severe vision loss, although certain complications may require specialized treatment.
Long-term care may include:
Dietary recommendations may change as kidney function changes.
Because Alport syndrome is inherited, genetic counseling can be useful for affected families.
Family members may be offered:
The specific approach depends on the genetic variant and family history.
Medical evaluation is important when there is:
Severe changes in kidney function or sudden visual symptoms may require urgent assessment.
Alport syndrome is a genetic condition that can progressively affect the kidneys, hearing, and eyes. Although there is no definitive cure, early kidney-protective treatment, particularly appropriate use of ACE inhibitors or ARBs, can help slow kidney disease progression.